Electronic patient education systems look great, offer flexibility in what’s communicated and can be branded with your logo. Goodbye textbooks!

Cataract surgery and IOL implantation have come a long way since the 1990s, and it appears that technical innovations are stoking demand more than medical need.

Medscape assessed the lifestyles of physicians; of the twenty-six specialties covered, ophthalmologists have the most to boast about.

In the UK, real-world visual outcomes of patients receiving ranibizumab for neovascular AMD fail to match those achieved in most randomized trials. But they were delivered with substantially fewer injections and hospital visits.

Received wisdom says that there is a critical period after birth during which the brain is wired for sight; blindness then means blindness for life

Google is developing contact lenses that will help patients monitor their glucose status. The technology is not entirely new, but the company’s infrastructure, experience and muscle suggest that it could have a substantial medical and commercial impact.

Carl Zeiss and Aaren buy, Alimera raise working capital and Novo A/S make a milestone payment to Ophthotech for Fovista.

An unexpected and simple advance has made stem cell production much easier and safer. Do STAP stem cells bring the treatment, even cure, of ocular disease a lot closer?

The EMA approved the first gene therapy agent in 2012 – for lipoprotein lipase deficiency. Might gene therapies for ophthalmic disease reach the wards any time soon?

OCT imaging visualizes retinal nerve fiber layers and the thickness of the macula; abnormalities in either can predict the stage and duration of schizophrenia.